SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Experimental Cancer Pharmaceuticals Under Trial
October 24, 2007
 · 
1 min read
Drug Development
New Inhibitor Has Potential as Cancer Drug, Uppsala Universitet Study
October 22, 2007
 · 
1 min read
Drug Development
Animal Study Identifies Potential Treatment for Huntington’s Disease
October 9, 2007
 · 
1 min read
Drug Development
“Promising Drug” for Child Cancer
October 3, 2007
 · 
1 min read
Drug Development
Deadline Approaches for Animal Experimentation Directive
September 25, 2007
 · 
1 min read
Drug Development
Smart Insulin Nanostructures Pass Feasibility Test, University of Texas Study Reports
September 21, 2007
 · 
1 min read
Drug Development
Sirtris Pharmaceuticals Eyes Longer-Life Drug: Cambridge Biotech Co. Synthesizes Properties in Red Wine
September 4, 2007
 · 
1 min read
Drug Development
Stem Cells Effective in Regenerating Damaged Heart Muscle in Animal Study
August 27, 2007
 · 
6 min read
Drug Development
Plant Compounds Blunt Menopausal Effects in Rats
August 16, 2007
 · 
1 min read
Drug Development
UT Southwestern Medical Center: Preclinical Study Suggests Organ-Transplant Drug May Aid in Lupus Fight
August 16, 2007
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer TypesTH1902 anti-tumor post-treatment effect persists longer than with docetaxel alone
April 10, 2021
 · 
8 min read
Drug Development
Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT-1660 in Three Posters at Virtual 2021 AACR Annual Meeting
April 10, 2021
 · 
10 min read
Drug Development
Zymeworks Showcases Preclinical Assets, Including New Therapeutic Platform, ProTECT™, and Zanidatamab Mechanisms of Action at AACR Annual Meeting
April 10, 2021
 · 
11 min read
Drug Development
Molecular Partners Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR
April 10, 2021
 · 
8 min read
Drug Development
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021
April 10, 2021
 · 
8 min read
Drug Development
Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting
April 10, 2021
 · 
6 min read
Drug Development
ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting
April 10, 2021
 · 
4 min read
Drug Development
Tachyon Presents Promising Preclinical Data on Its First-in-class Pan-KDM4 Epigenetic Regulator, TACH101
April 10, 2021
 · 
3 min read
Drug Development
Elevation Oncology Announces the Presentation of New Preclinical Data in Pancreatic and Cholangiocarcinoma PDX Models on the Specific Inhibition of HER3 with Seribantumab to Block NRG1 Fusion Signaling
April 10, 2021
 · 
6 min read
Drug Development
SQZ Biotech Presents Preclinical Data on its mRNA-based enhanced APCs and the Potential of the SQZ APC Platform in KRAS Driven Tumors
April 10, 2021
 · 
6 min read
Drug Development
ESSA Pharma Presents Preclinical Data Supporting the Therapeutic Potential of EPI-7386 at the 2021 American Association of Cancer Research (AACR) Annual Meeting
April 10, 2021
 · 
7 min read
Drug Development
MEI Pharma Reports Preclinical Data Demonstrating Ability of Voruciclib to Regulate MYC and Synergize with KRAS Inhibitors in KRAS Mutant Cancers
April 10, 2021
 · 
6 min read
Drug Development
Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2021
April 10, 2021
 · 
11 min read
Drug Development
Fusion Pharmaceuticals Announces Preclinical Combination Data Demonstrating Enhanced Efficacy in Multiple Preclinical Tumor Models
April 10, 2021
 · 
6 min read
Drug Development
Nuvalent Presents Preclinical Data Demonstrating That ROS1 Inhibitor NUV-520 and ALK Inhibitor NUV-655 are Selective, Brain-Penetrant, and Active Against Drug-Resistance Mutations
April 10, 2021
 · 
5 min read
Drug Development
CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell Function
April 10, 2021
 · 
5 min read
Drug Development
Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021
April 10, 2021
 · 
6 min read
Drug Development
Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
April 10, 2021
 · 
7 min read
Drug Development
Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting
April 10, 2021
 · 
4 min read
Drug Development
Gennao Bio Presents New Data on Novel Gene Monoclonal Antibody Platform Technology at the American Association for Cancer Research (AACR) 2021 Annual Meeting
April 10, 2021
 · 
3 min read
Load More